recent
emerg
reemerg
virus
avian
influenza
virus
middl
east
respiratori
syndrom
coronaviru
merscov
zika
viru
zikv
ebola
viru
ebov
repres
global
public
health
concern
newli
emerg
virus
aris
humancontact
wild
domest
anim
pose
new
challeng
human
immun
system
induc
sever
diseas
caus
high
mortal
oliv
et
al
clinic
featur
patient
infect
merscov
avian
influenza
virus
character
sever
pneumonia
differ
fatal
ratio
assiri
et
al
de
groot
et
al
gao
et
al
wu
gao
zikv
infect
gener
mild
rang
asymptomat
infect
febril
ill
character
headach
arthralgia
myalgia
maculopapular
rash
conjunct
vomit
fatigu
howev
sever
neurolog
complic
associ
zikv
infect
syndrom
gb
adult
congenit
birth
defect
includ
microcephali
develop
fetu
emerg
recent
epidem
make
zikv
emerg
public
health
emerg
brasil
et
al
de
et
al
ebola
viru
first
identifi
central
africa
reemerg
end
west
africa
high
mortal
rate
baiz
et
al
liu
though
divers
clinic
manifest
observ
infecti
diseas
similar
immun
featur
correl
diseas
sever
patient
high
level
proinflammatori
cytokin
chemokin
term
hypercytokinaemia
lymphopenia
thrombocytopenia
earli
stage
infect
also
extens
tissu
infiltr
immun
cell
assiri
et
al
tan
et
al
howev
magnitud
time
phase
longev
virusspecif
serolog
tcell
respons
repres
differ
though
data
adapt
immun
respons
emerg
virus
patient
remain
limit
liu
et
al
demonstr
immun
featur
virus
provid
benefici
recommend
clinic
intervent
vaccin
develop
diseas
mandl
et
al
although
popul
suscept
new
virus
infect
previous
emerg
virus
genet
correl
current
emerg
virus
may
induc
crossimmun
respons
human
mean
preexist
immun
respons
may
elicit
evid
preexist
tcell
immun
establish
previou
infect
relat
virus
would
abl
recogn
conserv
epitop
sometim
even
crossrecogn
mutat
epitop
therebi
help
host
clear
novel
virus
also
shed
light
univers
vaccin
develop
et
al
wang
et
al
howev
preexist
cellular
immun
could
doubleedg
sword
sometim
host
could
mount
cytotox
lymphocyt
ctl
target
previou
strain
weak
respons
immunogen
variant
present
origin
antigen
sin
tcell
mcmichael
origin
antigen
sin
correl
preexist
tcell
might
result
anergi
enhanc
diseas
cobey
hensley
crossreact
denguespecif
tcell
cohort
hlaa
individu
show
suboptim
granul
high
cytokin
product
like
lead
immunopatholog
mongkolsapaya
et
al
thu
time
summar
analysi
featur
tcell
immun
patient
toward
newli
emerg
reemerg
virus
potenti
crossimmun
reactiv
popul
import
refer
clinic
basic
research
emerg
viral
diseas
influenza
viru
infect
patient
develop
sever
respiratori
ill
acut
respiratori
distress
syndrom
pneumonia
show
high
tcell
respons
inflammatori
cytokin
lung
peripher
blood
goraya
et
al
guo
et
al
huang
et
al
wang
et
al
tcell
patient
sever
infect
present
delay
respons
acut
phase
nonspecif
stimul
streptococcu
antigen
tcell
statu
abnorm
sever
affect
patient
one
month
post
infect
compar
patient
mild
symptom
chen
et
al
diao
et
al
patient
differ
hospit
period
observ
earli
robust
tcell
respons
correl
rapid
recoveri
sever
diseas
observ
studi
indic
tcell
especi
tcell
may
play
pivot
role
protect
sever
diseas
envelop
protein
viru
hemagglutinin
ha
neuraminidas
na
get
mutat
frequent
intern
protein
share
highli
conserv
sequenc
matrix
nucleoprotein
np
polymeras
basic
show
similar
respect
align
viru
among
intern
protein
np
possess
domin
immunogen
tcell
immun
grant
et
al
lee
et
al
liu
et
al
despit
decreas
tcell
epitop
immunogen
owe
substitut
moder
level
crossreact
tcell
respons
season
influenza
virus
van
de
sandt
et
al
et
al
show
immunogen
peptid
deriv
could
recogn
memori
tcell
gener
former
influenza
infect
recognit
abil
vari
among
differ
ethnic
et
al
van
de
sandt
et
al
found
tcell
peripher
blood
healthi
popul
collect
epidem
could
crossreact
virus
van
de
sandt
et
al
variant
np
epitop
could
recogn
tcell
deriv
hlab
subject
crossreact
differ
influenza
virus
may
contribut
immunodomin
tcell
epitop
indic
previou
studi
figur
liu
et
al
liu
et
al
immunoinformat
analys
duvvuri
et
al
show
nearli
half
predict
conserv
epitop
deriv
intern
protein
could
induc
tcell
immun
furthermor
observ
differ
studi
mice
crossreact
memori
tcell
could
offer
heterosubtyp
protect
hierarchi
might
depend
size
memori
tcell
pool
duan
et
al
mcmaster
et
al
thu
preexist
crossreact
tcell
immun
establish
season
influenza
viru
infect
popul
may
contribut
viru
clearanc
symptom
relief
patient
despit
wide
exist
crossreact
tcell
immun
influenza
virus
also
notic
virusspecif
substitut
tcell
epitop
could
induc
immun
evas
subject
et
al
substitut
human
leucocyt
antigen
hla
tcell
epitop
np
viru
compar
season
influenza
virus
made
peptidemajor
histocompat
complex
mhc
less
stabl
access
cytotox
tcell
et
al
van
de
sandt
et
al
group
identifi
two
amino
acid
substitut
hlaa
np
led
dramat
antigen
variabl
correspond
tcell
epitop
figur
b
gener
base
combin
structur
function
studi
elucid
immunogenet
variat
majorli
modul
substitut
impact
hlabind
tcell
receptor
tcr
recognit
influenza
virusspecif
tcell
immun
could
last
long
term
van
de
sandt
et
al
demonstr
influenza
virusspecif
ctl
longliv
follow
donor
van
de
sandt
et
al
howev
noteworthi
among
tcell
establish
former
influenza
infect
might
tcell
tcr
target
subdomin
epitop
bare
induc
tcell
respons
previou
studi
ctl
lymphocyt
choriomening
viru
lcmv
infect
show
viru
could
escap
immun
system
via
vari
mutant
could
gener
helpless
ctl
thu
result
origin
antigen
sin
klenerman
zinkernagel
mcmichael
immun
respons
focus
conserv
epitop
may
effici
activ
new
influenza
strain
develop
mutat
conserv
region
result
immun
anergi
diseas
progress
zikv
mosquitotransmit
flaviviru
first
isol
uganda
febril
rhesu
macaqu
recent
rocket
public
health
emerg
due
rapid
dissemin
america
southeast
asian
countri
dick
et
al
hazin
et
al
zhang
et
al
sever
zikv
case
import
china
first
zikv
strain
return
travel
isol
analyz
deng
et
al
deng
et
al
although
zikv
infect
known
occasion
caus
mild
ill
evid
zikv
infect
lead
sever
birth
defect
includ
microcephali
neurolog
complic
may
develop
guillainbarr
syndrom
calvet
et
al
caolormeau
et
al
addit
arthropod
born
transmiss
sexual
transmisfigur
color
onlin
mhc
tetramerbas
detect
antigenspecif
tcell
emerg
reemerg
virus
evalu
viru
antigenspecif
tcell
respons
human
anim
model
tetram
mhc
icomplex
virusderiv
epitop
gener
lab
util
stain
tcell
ratio
tetram
posit
cell
tcell
shown
percentag
pbmc
freshlyisol
hlaa
healthi
control
subject
recov
season
influenza
viru
infect
analyz
use
hlaa
tetram
peptid
immunodomin
tcell
epitop
highlyconserv
differ
influenza
virus
includ
b
b
e
tetram
util
analyz
zikvspecif
tcell
freshlyisol
lymphocyt
spleen
spinal
cord
brain
mice
immun
zikv
vaccin
infect
zikv
control
spleen
mice
immun
placebo
adenovirusvector
base
zikv
vaccin
respect
spinal
cord
brain
mice
infect
zikv
freshlyisol
lymphocyt
spinal
cord
brain
analyz
use
tetram
c
pbmc
freshli
isol
healthi
control
sar
recoveri
patient
cultur
analyz
hlaa
tetram
merscovspecif
tcell
splenocyt
balbc
mice
inocul
merscov
antigenexpress
vaccin
cultur
stimul
peptid
nine
day
subsequ
stain
tetram
sion
confirm
detect
infecti
zikv
patient
semen
make
zikv
threat
human
dortenzio
et
al
mansuy
et
al
besid
sever
studi
highlight
role
zikv
infect
induc
infertil
mous
model
dortenzio
et
al
govero
et
al
et
al
public
health
crisi
underpin
import
complet
understand
viral
pathogenesi
induct
protect
immun
respons
zikv
infect
contrast
gener
neutral
antibodi
wang
et
al
littl
known
tcellmedi
immun
amongst
zikv
sever
studi
indic
tcell
play
protect
role
flaviviru
infect
anim
lack
tcell
mhc
show
reduc
viral
clearanc
capac
elong
ngono
et
al
determin
sever
newli
map
antigen
epitop
zikvinfect
lysmcr
ifnar
flfl
b
demonstr
protect
role
tcell
infect
elong
ngono
et
al
infect
mild
result
minim
morbid
zikvinfect
immunocompet
mous
model
zikvspecif
tcell
could
protect
central
nervou
system
cn
zikv
infect
crossprotect
mice
dengu
viru
denv
infect
huang
et
al
pardi
et
al
tcell
epitop
b
phenotyp
also
identifi
protein
zikv
howev
signific
portion
tcell
epitop
deriv
envelop
protein
elong
ngono
et
al
huang
et
al
pardi
et
al
moreov
wen
et
al
identifi
hlab
epitop
one
hlaa
epitop
zikvinfect
interferon
ifn
receptordefici
hla
transgen
mice
wen
et
al
recent
found
e
specif
tcell
exist
zikvinfect
cn
import
implic
design
develop
effect
zikv
vaccin
figur
huang
et
al
anoth
studi
demonstr
chimpanze
adenoviru
vectorbas
zikv
vaccin
express
glycoprotein
induc
specif
tcell
immun
mice
figur
kun
xu
meanwhil
tcell
shown
contribut
immun
protect
via
abil
produc
proinflammatori
cytokin
support
antibodi
respons
lai
et
al
found
zikv
patient
tcell
moder
activ
produc
antivir
cytokin
stimul
zikv
c
prm
e
proteinderiv
peptid
lai
et
al
tapp
et
al
describ
clinic
syndrom
laboratori
diagnost
procedur
clinic
zikvinfect
patient
studi
dynam
respons
cytokin
acut
reconvalesc
phase
zikv
infect
tapp
et
al
gener
activ
cell
peak
day
decreas
day
howev
huang
et
al
show
viru
specif
memori
cell
could
exist
day
zikv
infect
indic
tcell
respons
zikv
could
last
long
huang
et
al
anoth
import
caus
concern
potenti
tcell
crossreact
differ
flavivirus
sever
studi
show
similar
extent
tcell
crossreact
exist
zikv
flaviviru
owe
high
amino
acid
ident
denv
yellow
fever
viru
yfv
west
nile
viru
wnv
japanes
enceph
viru
jev
tabl
potenti
crossreact
zikv
denv
also
indic
structur
analysi
virusderiv
peptid
complex
hla
molecul
figur
wen
et
al
identifi
zikvdenv
crossreact
epitop
elicit
tcell
respons
reduc
infecti
zikv
level
well
alter
immunodomin
pattern
denvimmun
set
rel
naiv
type
tabl
wen
et
al
similarli
virusspecif
tcell
induc
previou
denv
infect
predominantli
mediat
crossprotect
respons
zikv
mice
wen
et
al
recent
studi
show
zikv
ereact
memori
tcell
low
crossreact
denv
tabl
stettler
et
al
howev
humor
immun
shown
denv
antibodi
crossreact
zikv
enhanc
zikv
infect
mediat
antibodydepend
enhanc
ade
bardina
et
al
although
mani
studi
explor
crossreact
denv
zikv
humor
cellular
immun
dual
role
crossreact
tcell
flavivirus
protect
pathogenesi
remain
unknown
crossreact
tcell
zikv
may
also
lead
failur
appropri
immun
respons
flaviviru
serotyp
origin
antigen
sin
occur
flaviviru
crossreact
tcell
mongkolsapaya
et
al
discuss
origin
antigen
sin
context
suboptim
degranul
crossreact
denguespecif
tcell
besid
high
cytokin
storm
denv
infect
mongkolsapaya
et
al
thu
research
focu
vaccin
develop
zikv
especi
applic
recipi
previous
infect
flavivirus
denv
halstead
mongkolsapaya
et
al
urgenc
determin
mechan
origin
tcell
antigen
sin
flavivirus
might
benefit
futur
efficaci
vaccin
formul
antivir
therapi
sinc
first
identif
caus
agent
hemorrhag
fever
syndrom
democrat
republ
congo
ebola
viru
diseas
evd
infect
thousand
human
case
fatal
rate
chowel
nishiura
recent
evd
outbreak
west
africa
largest
epidem
histori
confirm
probabl
case
studi
anim
model
provid
insight
immun
respons
ebov
infect
zeng
et
al
howev
human
immun
respons
poorli
investig
mainli
outbreak
occur
remot
area
africa
current
studi
base
limit
blood
specimen
ebov
patient
indic
hypercytokinemia
common
acut
phase
human
infect
ruibal
et
al
use
luminex
technolog
tcellrel
immun
mediat
analysi
ebola
patient
blood
sampl
obtain
gabon
republ
congo
show
aberr
innat
immun
reaction
character
cytokin
storm
hypersecret
numer
proinflammatori
cytokin
chemokin
growth
factor
wauquier
et
al
especi
among
pediatr
patient
younger
year
age
one
surviv
higher
level
chemokin
regul
activ
normal
tcell
express
secret
marker
rant
lower
level
plasminogen
activ
inhibitor
solubl
intracellular
adhes
molecul
kam
et
al
solubl
vascular
cell
adhes
molecul
vcam
compar
pediatr
patient
die
mcelroy
et
al
lymphocyt
propos
critic
clearanc
protect
ebov
infect
sequencebas
hlab
type
perform
use
leukocyt
isol
sudan
viru
sudv
patient
outbreak
northern
uganda
indic
allel
b
b
associ
fatal
outcom
wherea
b
b
associ
nonfat
outcom
suggest
pivot
role
hlarestrict
tcell
respons
antiviru
process
sanchez
et
al
immunosuppress
fatal
pediatr
patient
character
low
level
circul
cytokin
produc
lymphocyt
massiv
loss
peripher
lymphocyt
wauquier
et
al
anoth
studi
base
patient
outbreak
gabon
show
although
activ
tcell
indic
consider
releas
plasma
could
observ
earli
diseas
stage
fatal
case
patient
character
disappear
tcellrel
mrna
includ
day
preced
death
indic
import
role
tcell
immun
respons
viru
clearanc
baiz
et
al
recent
evd
outbreak
west
africa
analysi
fatal
patient
use
multiparametr
flow
cytometri
establish
field
show
character
high
percentag
tcell
express
inhibitori
molecul
ctlassoci
antigen
program
death
corr
tabl
tcell
crossreact
zikv
flavivirus
virusesvaccin
immun
target
antigen
test
crossreact
human
zikv
denv
late
elev
inflammatori
marker
high
viru
load
ruibal
et
al
convers
surviv
individu
show
significantli
lower
express
still
compar
overal
tcell
activ
studi
indic
robust
ebovspecif
tcell
respons
might
play
pivot
role
viru
clearanc
could
help
surviv
patient
anoth
unconvent
featur
immun
respons
ebov
persist
activ
longterm
immun
memori
post
infect
mcelroy
et
al
sobarzo
et
al
tcell
test
data
four
ebola
patient
emori
univers
show
ebolaspecif
tcell
still
activ
one
month
recoveri
patient
remain
detect
day
diseas
onset
mcelroy
et
al
howev
magnitud
cell
respons
vari
along
time
mount
activ
cell
respons
hladr
went
one
month
post
infect
went
eventu
mcelroy
et
al
consid
longterm
persist
viral
rna
bodi
fluid
survivor
valuabl
detect
immun
respons
post
ebov
infect
may
help
ident
use
immun
biomark
persist
viral
rna
thorson
et
al
zeng
et
al
novel
human
infect
coronaviru
call
merscov
first
report
middl
east
countri
zaki
et
al
soon
import
case
diagnos
european
african
american
asian
countri
su
et
al
wong
et
al
outbreak
merscov
character
local
humantohuman
transmiss
occur
south
korea
clinic
featur
patient
infect
merscov
quit
similar
infect
sever
acut
respiratori
syndrom
sar
cov
ie
sever
pneumonia
acut
respiratori
distress
syndrom
ard
hong
et
al
moreov
sever
merscov
infect
also
character
renal
dysfunct
observ
much
lower
number
sarscov
infect
cha
et
al
chu
et
al
recent
studi
strongli
elucid
pivot
role
virusassoci
immunopatholog
event
caus
fatal
pneumonia
mer
sar
patient
often
associ
massiv
inflammatori
cell
infiltr
elev
proinflammatori
cytokinechemokin
respons
term
hypercytokinemia
patient
channappanavar
perlman
immunopathologyrel
mediat
interleukin
elev
import
case
chines
individu
return
south
korea
acut
infect
phase
da
guan
et
al
howev
level
antivir
adapt
immun
responseassoci
cytokin
lower
fatal
case
patient
surviv
faur
et
al
data
indic
dysregul
immun
responseassoci
lung
immunopatholog
merscovinfect
patient
might
lead
deleteri
clinic
manifest
addit
recent
evid
alqahtani
et
al
show
captur
human
merscov
protein
suppress
macrophag
respons
via
induct
tolllik
receptor
tlr
signal
discoveri
verifi
previou
observ
potenti
impact
merscov
sarscov
host
immun
respons
interact
receptor
liu
et
al
studi
merscovspecif
tcell
respons
patient
peripher
blood
mononuclear
cell
pbmc
obtain
import
case
china
day
ill
strong
specif
tcell
respons
merscov
protein
observ
da
guan
et
al
studi
followup
sar
survivor
found
sarscov
n
proteinspecif
tcell
could
exist
peripher
blood
long
period
figur
liu
et
al
liu
et
al
ng
et
al
interestingli
found
sarscov
proteinspecif
tcell
could
still
detect
healthcar
worker
infect
sarscov
year
ago
low
level
crosstcel
respons
merscov
protein
could
also
detect
da
guan
et
al
contrast
direct
crossreact
sarscov
antigen
mer
patient
survivor
yet
report
recent
studi
merscovspecif
tcell
respons
detect
anim
model
viru
infect
vaccin
immun
pivot
role
antiviru
protect
welldefin
figur
lan
et
al
liu
et
al
crossreact
sarscov
merscov
also
detect
anim
model
zhao
et
al
found
previous
identifi
conserv
tcell
epitop
recogn
transgen
mice
infect
either
sarscov
merscov
show
certain
level
protect
effect
previou
analysi
also
indic
rel
conserv
tcell
epitop
limit
substitut
sarscov
merscov
may
still
possess
crossreact
immunogen
liu
et
al
essenti
crystal
structur
peptid
sarscov
complex
hlaa
model
substitut
peptid
merscov
complex
hlaa
show
quit
similar
conform
figur
f
indic
potenti
crossreact
thu
investig
still
need
elucid
complet
landscap
immunogen
relationship
highli
pathogen
sarscov
merscov
although
time
character
tcell
immun
emerg
reemerg
virus
provid
benefici
refer
clinic
intervent
vaccin
develop
mani
aspect
gener
mechan
cellmedi
immun
viral
diseas
remain
poorli
understood
sever
techniqu
commonli
use
detect
antigenspecif
tcell
includ
cell
prolifer
assay
cytotox
assay
intracellular
cytokin
stain
ic
enzymelink
immunosorb
spot
elispot
assay
peptidemhc
tetram
stain
pentamermultim
stain
howev
systemat
approach
requir
comprehens
understand
virusspecif
tcell
immun
liu
et
al
key
domin
immun
mediat
immunopathogenesisrel
hypercytokinemia
acut
phase
viral
infect
well
defin
although
heterosubtyp
protect
induc
tcell
immun
respons
differ
subtyp
influenza
virus
evid
possibl
develop
tcellbas
univers
vaccin
genet
relat
virus
still
debat
also
concern
recent
reemerg
zikv
flavivirus
denv
furthermor
well
determin
whether
longlast
virusspecif
tcell
survivor
still
contribut
toward
effect
protect
reinfect
viru
even
crossprotect
geneticallyrel
virus
longterm
followup
survivor
develop
new
anim
model
preclin
trial
may
futur
orient
studi
focus
emerg
reemerg
virus
